The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Allakos Inc | COM | 01671P100 | 18,878 | 446,905 | SH | SOLE | 446,905 | 0 | 0 | ||
| Aravive Inc | COM | 03890D108 | 2,656 | 442,733 | SH | SOLE | 442,733 | 0 | 0 | ||
| Atreca Inc | COM | 04965G109 | 11,141 | 591,368 | SH | SOLE | 591,368 | 0 | 0 | ||
| Catabasis Pharmaceuticals Inc | COM | 14875P206 | 2,421 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| Evelo Biosciences Inc | COM | 299734103 | 2,043 | 227,529 | SH | SOLE | 227,529 | 0 | 0 | ||
| Gossamer Bio Inc | COM | 38341P102 | 8,353 | 376,583 | SH | SOLE | 376,583 | 0 | 0 | ||
| Hookipa Pharma Inc | COM | 43906K100 | 3,569 | 530,245 | SH | SOLE | 530,245 | 0 | 0 | ||
| Intercept Pharmaceuticals Inc | COM | 45845P108 | 26,314 | 330,697 | SH | SOLE | 330,697 | 0 | 0 | ||
| KalVista Pharmaceuticals Inc | COM | 483497103 | 2,625 | 118,500 | SH | SOLE | 118,500 | 0 | 0 | ||
| Liquidia Technologies Inc | COM | 53635D202 | 5,268 | 658,532 | SH | SOLE | 658,532 | 0 | 0 | ||
| Millendo Therapeutics Inc | COM | 60040X103 | 521 | 45,101 | SH | SOLE | 45,101 | 0 | 0 | ||
| Odonate Therapeutics Inc | COM | 676079106 | 22,596 | 615,850 | SH | SOLE | 615,850 | 0 | 0 | ||
| PDS Biotechnology Corp | COM | 70465T107 | 55 | 9,166 | SH | SOLE | 9,166 | 0 | 0 | ||
| Principia Biopharma Inc | COM | 74257L108 | 12,728 | 383,480 | SH | SOLE | 383,480 | 0 | 0 | ||
| Regulus Therapeutics Inc | COM | 75915K200 | 1,131 | 904,407 | SH | SOLE | 904,407 | 0 | 0 | ||
| Sunesis Pharmaceuticals Inc | COM | 867328700 | 1,534 | 2,110,913 | SH | SOLE | 2,110,913 | 0 | 0 | ||
| Surface Oncology Inc | COM | 86877M209 | 221 | 78,300 | SH | SOLE | 78,300 | 0 | 0 | ||
| Sutro BioPharma Inc | COM | 869367102 | 12,809 | 1,125,579 | SH | SOLE | 1,125,579 | 0 | 0 | ||
| Syros Pharmaceuticals Inc | COM | 87184Q107 | 15,228 | 1,726,603 | SH | SOLE | 1,726,603 | 0 | 0 | ||
| Trillium Therapeutics Inc | COM | 89620X506 | 24 | 71,619 | SH | SOLE | 71,619 | 0 | 0 | ||
| Urovant Sciences Ltd | COM | G9381B108 | 1,246 | 157,480 | SH | SOLE | 157,480 | 0 | 0 | ||